These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6390452)

  • 1. Hemoglobin solution--from tetramer to polymer.
    Moss GS; Gould SA; Sehgal LR; Sehgal HL; Rosen AL
    Prog Clin Biol Res; 1984; 165():191-210. PubMed ID: 6390452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin solution--from tetramer to polymer.
    Moss GS; Gould SA; Sehgal LR; Sehgal HL; Rosen AL
    Surgery; 1984 Mar; 95(3):249-55. PubMed ID: 6701780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.
    Sehgal LR; Gould SA; Rosen AL; Sehgal HL; Moss GS
    Surgery; 1984 Apr; 95(4):433-8. PubMed ID: 6710339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modified hemoglobin solutions as artificial oxygen carriers].
    Lenz G; Bissinger U
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():63-7. PubMed ID: 7841783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of pyridoxalated-polymerized hemoglobin solution.
    Friedman HI; De Venuto F; Schwartz BD; Nemeth TJ
    Surg Gynecol Obstet; 1984 Nov; 159(5):429-35. PubMed ID: 6495140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and viral inactivation of hemoglobin from human placenta blood.
    Li F; Zhang H; Wang J; Yang C
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):57-60. PubMed ID: 19229697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified haemoglobins as oxygen-transporting blood substitutes.
    Mallick A; Bodenham AR
    Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contributions and prospects of hemoglobin derivatives].
    Remy B; Deby-Dupont G; Lamy M
    Schweiz Med Wochenschr; 1997 Jun; 127(25):1088-96. PubMed ID: 9312831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
    Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
    Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute.
    Chen YC; Chang WH; Chang Y; Huang CM; Sung HW
    Biotechnol Bioeng; 2004 Jul; 87(1):34-42. PubMed ID: 15211486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiologic effects of oxygen transport by hemoglobin solutions.
    Moores WY; White FC; Bloor C; Greenburg AG; Mack R; Willford DC
    Prog Clin Biol Res; 1983; 122():89-99. PubMed ID: 6878384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental assessment of the effectiveness of modified polyhemoglobin in the model of extreme hemodilution].
    Kolonina IR; Litvinenko IuA; Sokolov AV
    Biull Eksp Biol Med; 1991 May; 111(5):503-5. PubMed ID: 1878566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance.
    Page TC; Light WR; McKay CB; Hellums JD
    Microvasc Res; 1998 Jan; 55(1):54-64. PubMed ID: 9473409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of well-defined bovine polyhemoglobin based on dimethyl adipimidate and glutaraldebyde cross-linkage.
    Hu T; Su Z
    Biochem Biophys Res Commun; 2002 May; 293(3):958-61. PubMed ID: 12051752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectations and implications of blood sparing with hemoglobin based oxygen carriers.
    Estep TN
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):93-105. PubMed ID: 17364474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of erythrocyte substitutes.
    Biro GP
    Can Med Assoc J; 1983 Aug; 129(3):237-44. PubMed ID: 6344974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen transport in rats following total blood replacement with solutions of high-molecular modified hemoglobin].
    Ivanov KP; Samsonov GV; Bogomolova LG; Moiseeva OI; Chuikin AE
    Fiziol Zh SSSR Im I M Sechenova; 1981 Dec; 67(12):1814-22. PubMed ID: 7333374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of chemically modified hemoglobins as a basis for oxygen-carrying blood substitutes].
    Azhigirova MA; Viazova EP; Shuvalova AL; Vashkevich MG
    Biull Eksp Biol Med; 1993 Apr; 115(4):364-6. PubMed ID: 8049393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin solutions as red cell substitutes.
    Gould SA; Rosen AL; Sehgal L; Sehgal H; Rice CL; Moss GS
    Trans Am Soc Artif Intern Organs; 1980; 26():350-3. PubMed ID: 7245512
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinctive characteristics of pyridoxalated-polymerized hemoglobin.
    DeVenuto F; Zegna AI
    Prog Clin Biol Res; 1983; 122():29-39. PubMed ID: 6878372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.